CIPO Patents = 2

EPO Patents = 1

Trademarks = 2

Forward Citations = 12

Loading Chart...

7 inventors (with patents filed for the assignee):

Tamar Ben-Yedidia (3 out of 10 patents)

Yossi Singer (2 out of 2 patents)

Ram Uritski (1 out of 1 patent)

4. Barry Cohen (1 out of 1 patent)

5. Zohar Gadri (1 out of 1 patent)

6. Shimon Hassin (1 out of 1 patent)

7. George H Lowell (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 10426828 - Compositions of multimeric-multiepitope influenza polypeptides and their production (2019-10-01),

2. 9353159 - Multimeric multiepitope influenza vaccines (2016-05-31),

3. 9303070 - Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines (2016-04-05),

4. 8747861 - Multimeric multiepitope influenza vaccines (2014-06-10),

Biondvax Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative vaccines to prevent infectious diseases. Its lead product candidate, M-001, is a universal flu vaccine designed to provide multi-season and multi-strain protection. With a dedication to advancing public health through cutting-edge research and development, Biondvax is committed to improving global vaccine outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#21 in Ness Ziona

#1,353 in Israel

Ness Ziona, Israel

Biondvax Pharmaceuticals Ltd.

Forward Citations = 12

7 inventors:

Tamar Ben-Yedidia (3 out of 10 patents)

Yossi Singer (2 out of 2 patents)

Ram Uritski (1 out of 1 patent)

4. Barry Cohen (1 out of 1 patent)

5. Zohar Gadri (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com

2 patents (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com